首页> 外文期刊>World Journal of Gastroenterology >Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris.
【24h】

Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris.

机译:毕赤酵母中人干扰素α2b-(G4S)n-胸腺素α1融合蛋白的构建,表达和表征。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Interferon alpha2b (IFNalpha2b) and thymosin alpha1 (Talpha1) exhibit synergic effects in the treatment of hepatitis B and hepatitis C when used together. For developing a fusion protein drug, fusion proteins of IFNalpha2b and Talpha1 linked by different lengths of (G4S)n (n = 1-3) were constructed and expressed in Pichia pastoris. METHODS: Using PCR and molecular clone techniques, the fusion genes of IFNalpha2b-(G4S)n-Talpha1 (n = 1-3) were constructed and subcloned into the eukaryotic expression vector pPIC9. After transformation of these plasmids into P. pastoris, the expressed fusion proteins IFNalpha2b-(G4S)n-Talpha1 (n = 1-3) were obtained. These proteins were purified through diethylaminoethyl (DEAE) affinity chromatography and Superdex(TM) 75 gel filtration and analyzed by SDS-PAGE and Western blot. Antiviral and E-rosette assays were used to investigate the bioactivities of these fusion proteins. RESULTS: DNA sequencing confirmed that the fusion genes of IFNalpha2b-(G4S)n-Talpha1 (n = 1-3) were correctly cloned to the pPIC9 vector. The recombinant IFNalpha2b-(G4S)n-Talpha1 (n = 1-3) fusion proteins expressed in P. pastoris were purified with DEAE and Superdex(TM) 75 gel filtration chromatography. The fusion proteins could be observed on sodium dodecylsulfate-polyacrylamide gel electrophoresis with molecular weight (MW) of 23.2, 22.9, and 22.6 ku, respectively, and reacted to the IFNalpha2b monoclonal antibody and Talpha1 polyclonal antibody. The purified fusion proteins exhibit antiviral activity and can enhance the percentage of E-rosette-forming-cell in E-rosette assay. CONCLUSION: The recombinant IFNalpha2b-(G4S)n-Talpha1 (n = 1-3) fusion proteins were successfully expressed in P. pastoris. Purified fusion proteins exhibit both antiviral activity of IFNalpha2b and immunomodulatory activity of Talpha1 in vitro. These results will be the basis for further evaluation of the fusion proteins' function in vivo.
机译:目的:干扰素α2b(IFNalpha2b)和胸腺素α1(Talpha1)一起使用在乙型肝炎和丙型肝炎的治疗中表现出协同作用。为了开发融合蛋白药物,构建了通过不同长度的(G4S)n(n = 1-3)连接的IFNalpha2b和Talpha1融合蛋白,并在巴斯德毕赤酵母中表达。方法:利用PCR和分子克隆技术,构建IFNα2b-(G4S)n-Talpha1(n = 1-3)的融合基因,并将其亚克隆到真核表达载体pPIC9中。将这些质粒转化为巴斯德毕赤酵母后,获得表达的融合蛋白IFNalpha2b-(G4S)n-Talpha1(n = 1-3)。这些蛋白质通过二乙氨基乙基(DEAE)亲和色谱和SuperdexTM 75凝胶过滤纯化,并通过SDS-PAGE和Western blot分析。抗病毒和E-rosette检测用于研究这些融合蛋白的生物活性。结果:DNA测序证实IFNα2b-(G4S)n-Talpha1(n = 1-3)的融合基因已正确克隆到pPIC9载体中。用DEAE和Superdex TM 75凝胶过滤层析纯化在巴斯德毕赤酵母中表达的重组IFNalpha2b-(G4S)n-Talpha1(n = 1-3)融合蛋白。融合蛋白可以在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上观察到,分子量(MW)分别为23.2、22.9和22.6 ku,并与IFNalpha2b单克隆抗体和Talpha1多克隆抗体反应。纯化的融合蛋白表现出抗病毒活性,并可以在E-rosette分析中提高E-rosette形成细胞的百分比。结论:重组干扰素α2b-(G4S)n-Talpha1(n = 1-3)融合蛋白在巴斯德毕赤酵母中成功表达。纯化的融合蛋白在体外表现出IFNalpha2b的抗病毒活性和Talpha1的免疫调节活性。这些结果将是进一步评估融合蛋白在体内功能的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号